Oragenics Inc (OGEN)
:OGEN
Want to see OGEN full AI Analyst Report?
Total Valuation
Oragenics has a market cap or net worth of $2.93M. The enterprise value is $226.01M.
Market Cap$2.93M
Enterprise Value$226.01M
Share Statistics
Oragenics has 4,336,029 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,336,029
Owned by Insiders3.50%
Owned by Institutions4.02%
Financial Efficiency
Oragenics’s return on equity (ROE) is -1.19 and return on invested capital (ROIC) is -3.92%.
Return on Equity (ROE)-1.19
Return on Assets (ROA)-0.98
Return on Invested Capital (ROIC)-3.92%
Return on Capital Employed (ROCE)-1.13
Revenue Per Employee0.00
Profits Per Employee-3.28B
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Oragenics is ―. Oragenics’s PEG ratio is -0.00093.
PE Ratio―
PS Ratio0.00
PB Ratio0.20
Price to Fair Value0.20
Price to FCF>-0.01
Price to Operating Cash Flow-0.33
PEG Ratio-0.00093
Income Statement
In the last 12 months, Oragenics had revenue of 0.00 and earned -9.84M in profits. Earnings per share was -4.56.
Revenue0.00
Gross Profit0.00
Operating Income-9.36M
Pretax Income-9.98M
Net Income-9.84M
EBITDA-9.36M
Earnings Per Share (EPS)-4.56
Cash Flow
In the last 12 months, operating cash flow was -9.25M and capital expenditures -5.00, giving a free cash flow of -9.25M billion.
Operating Cash Flow-9.25M
Free Cash Flow-9.25M
Free Cash Flow per Share-2.13
Dividends & Yields
Oragenics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.22
52-Week Price Change-87.12%
50-Day Moving Average0.72
200-Day Moving Average1.02
Relative Strength Index (RSI)55.75
Average Volume (3m)211.78K
Important Dates
Oragenics upcoming earnings date is Aug 12, 2024, TBA (Confirmed).
Last Earnings DateMay 13, 2024
Next Earnings DateAug 12, 2024
Ex-Dividend Date―
Financial Position
Oragenics as a current ratio of 5.64, with Debt / Equity ratio of 2745.28%
Current Ratio5.64
Quick Ratio5.64
Debt to Market Cap134.57
Net Debt to EBITDA-23.81
Interest Coverage Ratio-11.91
Taxes
In the past 12 months, Oragenics has paid -136.91K in taxes.
Income Tax-136.91K
Effective Tax Rate0.01
Enterprise Valuation
Oragenics EV to EBITDA ratio is -23.99, with an EV/FCF ratio of -0.02.
EV to Sales0.00
EV to EBITDA-23.99
EV to Free Cash Flow-0.02
EV to Operating Cash Flow-0.02
Balance Sheet
Oragenics has $8.40M in cash and marketable securities with $227.35M in debt, giving a net cash position of -$218.95M billion.
Cash & Marketable Securities$8.40M
Total Debt$227.35M
Net Cash-$218.95M
Net Cash Per Share-$50.50
Tangible Book Value Per Share$3.84
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Oragenics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast90.27%